Countries citing papers authored by John S. Carter
Since
Specialization
Citations
This map shows the geographic impact of John S. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Carter more than expected).
This network shows the impact of papers produced by John S. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Carter. The network helps show where John S. Carter may publish in the future.
Co-authorship network of co-authors of John S. Carter
This figure shows the co-authorship network connecting the top 25 collaborators of John S. Carter.
A scholar is included among the top collaborators of John S. Carter based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with John S. Carter. John S. Carter is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Elkin, Peter L., et al.. (2011). Drug knowledge expressed as computable semantic triples.. PubMed. 166. 38–47.8 indexed citations
Carter, John S., Steven H. Brown, Brent A. Bauer, et al.. (2006). Categorical information in pharmaceutical terminologies.. PubMed. 116–20.19 indexed citations
4.
Brown, Steven H., et al.. (2004). Evaluation of SNOMED coverage of Veterans Health Administration terms.. PubMed. 107(Pt 1). 540–4.24 indexed citations
5.
Brown, Steven H., Peter L. Elkin, S. Trent Rosenbloom, et al.. (2004). VA National Drug File Reference Terminology: a cross-institutional content coverage study.. PubMed. 107(Pt 1). 477–81.68 indexed citations
6.
Lincoln, Michael, et al.. (2004). U.S. Department of Veterans Affairs Enterprise Reference Terminology strategic overview.. PubMed. 107(Pt 1). 391–5.23 indexed citations
7.
Chute, Christopher G., John S. Carter, Mark S. Tuttle, Margaret W. Haber, & Steven H. Brown. (2003). Integrating pharmacokinetics knowledge into a drug ontology: as an extension to support pharmacogenomics.. PubMed. 170–4.13 indexed citations
8.
Rosenbloom, S. Trent, Joseph Awad, Ted Speroff, et al.. (2003). Adequacy of representation of the National Drug File Reference Terminology Physiologic Effects reference hierarchy for commonly prescribed medications.. PubMed. 569–78.14 indexed citations
9.
Carter, John S., Steven H. Brown, Mark S. Erlbaum, et al.. (2002). Initializing the VA medication reference terminology using UMLS metathesaurus co-occurrences.. PubMed. 116–20.47 indexed citations
10.
Carter, John S., Steven H. Brown, Stuart J. Nelson, Michael Lincoln, & Mark S. Tuttle. (2001). The Creation and Use of a Reference Terminology for Inter-agency Computer-based Patient Records: The GCPR RTM Demonstration Project. Europe PMC (PubMed Central). 809–809.1 indexed citations
11.
Tuttle, Mark S., Steven H. Brown, Keith E. Campbell, et al.. (2001). The semantic web as Perfection seeking: a view from drug terminology. 5–16.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.